Bi- and Tri-Specific T Cell Engager-Armed Oncolytic Viruses: Next-Generation Cancer Immunotherapy

Oncolytic viruses (OVs) are potent anti-cancer biologics with a bright future, having substantial evidence of efficacy in patients with cancer. Bi- and tri-specific antibodies targeting tumor antigens and capable of activating T cell receptor signaling have also shown great promise in cancer immunot...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Zong Sheng, Lotze, Michael T., Zhu, Zhi, Storkus, Walter J., Song, Xiao-Tong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400484/
https://www.ncbi.nlm.nih.gov/pubmed/32664210
http://dx.doi.org/10.3390/biomedicines8070204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400484/
https://www.ncbi.nlm.nih.gov/pubmed/32664210
http://dx.doi.org/10.3390/biomedicines8070204

Ejemplares similares